Acquisition to expand Weave’s footprint in multi-location practices
An acquisition announced today will expand Weave Communications’ footprint in multi-location dental and medical practices, where demand for intelligent automation is accelerating amid staffing shortages and operational obstacles.
Weave, a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses (SMBs), has signed an agreement and plan of merger to acquire TrueLark, an AI-powered receptionist and front-desk automation platform. This strategic acquisition will bring together Weave’s category leadership in healthcare communications with TrueLark’s agentic AI capabilities, unlocking a future of autonomous, intelligent workflows that transform how practices operate, engage patients, and grow revenue.
“TrueLark represents more than a new product, the acquisition positions Weave at the forefront of agentic AI in SMB healthcare. Their purpose-built, AI-first platform brings autonomous, always-on functionality to core front-office operations,” said Brett White, CEO of Weave, in today’s press release. “The acquisition will deliver a virtual assistant that helps practices fill more appointments, improve responsiveness, and drive stronger patient engagement, all without increasing headcount.”
TrueLark’s platform leverages conversational AI to manage missed calls, text messages, and web chats to book and reschedule appointments, handle after-hours communication, and automate common administrative workflows to replicate and enhance front-office performance. This agentic AI model is designed to enable healthcare teams to shift from reactive communication to proactive engagement, ensuring every opportunity is captured, even outside of business hours.
The acquisition will expand Weave’s presence in multi-location practices. These groups have a demand for intelligent automation to help offset staffing shortages and operational strain. TrueLark has demonstrated strong product-market fit in appointment-based SMBs, including dental service organizations (DSOs). This makes their solution extremely compelling for Weave’s SMB healthcare verticals, the companies stated. With an estimated $10 billion domestic and $22 billion international addressable market following the acquisition, Weave and TrueLark will be uniquely positioned to lead the category and deliver exceptional ROI to customers through autonomous, always-on front-desk operations.
“Joining Weave gives us the opportunity to bring our AI innovation to a broader audience while continuing to push the boundaries of what’s possible in healthcare automation,” added Srivatsan Laxman, CEO and co-founder of TrueLark. “We’re excited to accelerate the next generation of intelligent practice communication together.”
Agentic AI Solution for Front-Office Gaps
At the closing, Weave and TrueLark will combine their strengths to address one of the healthcare industry’s most pressing challenges: the widening gap between patient requests and front-office availability. As intelligent assistants evolve from reactive bots to autonomous agents, the benefits to providers are transformative. They include:
- Fill more appointments with 24/7 availability and predictive rebooking
- Drive higher engagement through natural, AI-powered responses to patient inquiries
- Unlock scalable efficiency for DSOs, Management Service Organizations, and multi-location healthcare practices
- Reduce burnout and administrative burden with autonomous task handling
With this acquisition, Weave is reinforcing its position as the intelligent operating system for healthcare practices, expanding its platform to include always-on, AI-powered agents that deliver real-world results.
Under the terms of the agreement—expected to close in the second quarter of 2025—Weave will acquire all outstanding equity and ownership interest in TrueLark for $35 million, which comprises $25 million in cash and $10 million in equity, subject to customary purchase price adjustments. Additionally, the agreement includes a potential performance-based award for certain key personnel paid annually in stock over a two-year period.
